Debt decreased 100.0%
Debt changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 10 prior comparable changes.
$749.0M→$010 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →KVUE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Stock-based compensation decreased 13.5%
Stock-based compensation changed -13.5% from the comparable as-filed period. The change ranks at the 15th percentile of 20 prior comparable changes.
$37.0M→$32.0M20 prior comparisons
Net income increased 8.6%
Net income changed +8.6% from the comparable as-filed period. The change ranks at the 10th percentile of 20 prior comparable changes.
$420.0M→$456.0M20 prior comparisons
Cash & equivalents increased 3.7%
Cash & equivalents changed +3.7% from the comparable as-filed period. The change ranks at the 14th percentile of 37 prior comparable changes.
$1.1B→$1.1B37 prior comparisons
Gross margin moved 72 bp lower
Gross margin changed -72 basis points from the comparable as-filed period. The change ranks at the 45th percentile of 20 prior comparable changes.
58.90%→58.18%20 prior comparisons
Gross profit increased 1.8%
Gross profit changed +1.8% from the comparable as-filed period. The change ranks at the 15th percentile of 20 prior comparable changes.
$2.3B→$2.3B20 prior comparisons
Inventory decreased 3.0%
Inventory changed -3.0% from the comparable as-filed period. The change ranks at the 11th percentile of 18 prior comparable changes.
$1.8B→$1.7B18 prior comparisons
Operating income increased 1.0%
Operating income changed +1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 20 prior comparable changes.
$692.0M→$699.0M20 prior comparisons
Operating margin moved 35 bp lower
Operating margin changed -35 basis points from the comparable as-filed period. The change ranks at the 5th percentile of 20 prior comparable changes.
18.03%→17.67%20 prior comparisons
Research & development increased 3.3%
Research & development changed +3.3% from the comparable as-filed period. The change ranks at the 30th percentile of 20 prior comparable changes.
$91.0M→$94.0M20 prior comparisons
Revenue increased 3.0%
Revenue changed +3.0% from the comparable as-filed period. The change ranks at the 50th percentile of 20 prior comparable changes.
$3.8B→$4.0B20 prior comparisons
Selling, general & administrative increased 2.2%
Selling, general & administrative changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 20 prior comparable changes.
$1.5B→$1.5B20 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.